Cargando…

Clinical characteristics and outcomes in HIV-associated diffuse large B-cell lymphoma in China: A retrospective single-center study

Human immunodeficiency virus (HIV) infection is associated with an increased risk of aggressive lymphoma, especially diffuse large B cell lymphoma (DLBCL). There are few data regarding HIV-associated DLBCL in China. Therefore, we analyzed the characteristics and outcomes of patients with HIV-associa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Jiazhu, Miao, Yi, Qian, Chuan, Tao, Pengfei, Wang, Xicheng, Dong, Xingqi, Li, Xia, Lou, Jincheng, Liang, Jinhua, Xu, Wei, Li, Jianyong, Min, Haiyan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8040883/ https://www.ncbi.nlm.nih.gov/pubmed/33854591 http://dx.doi.org/10.7150/jca.51027

Ejemplares similares

Bortezomib depended on PRDM1 and TP53 to exert therapeutic effect in activated B-cell-like diffuse large B-cell lymphoma
por: Tang, Jing, et al.
Publicado: (2023)

Prevalence and Clinical Impact of Human Pegivirus-1 Infection in HIV-1-Infected Individuals in Yunnan, China
por: Miao, Zhijiang, et al.
Publicado: (2017)

Multiple primary malignancies in 788 Chinese patients with diffuse large B‐cell lymphoma
por: Zhang, Xuchang, et al.
Publicado: (2023)

Remission of HIV-related naïve and high-risk Burkitt’s lymphoma treated by autologous stem cell transplantation plus cART
por: Min, Haiyan, et al.
Publicado: (2018)

Dysregulation of Cell Survival in Diffuse Large B Cell Lymphoma: Mechanisms and Therapeutic Targets
por: Miao, Yi, et al.
Publicado: (2019)

P1155: MORE PRECISE RISK STRATIFICATION FOR TP53 MUTANT DIFFUSE LARGE B CELL LYMPHOMA
por: Du, Kai-Xin, et al.
Publicado: (2023)

Diffuse Large B-Cell Lymphoma in the HIV Setting
por: Huguet, Maria, et al.
Publicado: (2023)

Ovary involvement of diffuse large B-cell lymphoma
por: Hu, Rong, et al.
Publicado: (2012)

Zanubrutinib monotherapy for relapsed or refractory non-germinal center diffuse large B-cell lymphoma
por: Yang, Haiyan, et al.
Publicado: (2022)

The Impact of Low-Level Viraemia on Virological Failure—Results From a Multicenter HIV Antiretroviral Therapy Cohort Study in Yunnan, China
por: An, Jing, et al.
Publicado: (2022)

P1216: CD30 PROTECTS EBV-POSITIVE DIFFUSE LARGE B-CELL LYMPHOMA CELLS AGAINST MITOCHONDRIAL DYSFUNCTION THROUGH INCREASING BNIP3 EXPRESSION
por: Wang, Wei-Ting, et al.
Publicado: (2023)

PB2300: IMPACT OF INITIAL CHEMOTHERAPY CYCLES AND CLINICAL CHARACTERISTICS ON OUTCOMES FOR HIV-ASSOCIATED DIFFUSE LARGE B CELL LYMPHOMA PATIENTS: THE CENTRAL AND WESTERN CHINA AIDS LYMPHOMA LEAGUE STUDY
por: Wang, Chaoyu, et al.
Publicado: (2023)

Chidamide-BEAC plus autologous stem cell transplantation in high-risk non-Hodgkin lymphoma: a phase II clinical trial
por: Xia, Yi, et al.
Publicado: (2023)

Clinical Characteristics and Prognostic Factors in Primary Breast Diffuse Large B-Cell Lymphoma
por: Chen, Guang-Liang, et al.
Publicado: (2022)

Immune Characteristics of Chinese Diffuse Large B-Cell Lymphoma Patients: Implications for Cancer Immunotherapies
por: Xu, Peng-peng, et al.
Publicado: (2018)

Microsatellite instability and its associations with the clinicopathologic characteristics of diffuse large B‐cell lymphoma
por: Tian, Tian, et al.
Publicado: (2020)

PB2143: CLINICAL CHARACTERISTICS AND PROGNOSTIC FEATURES OF 63 HIV-ASSOCIATED DIFFUSE LARGE B-CELL LYMPHOMA: A SINGLE-CENTER REAL-WORLD STUDY IN CHINA
por: Wang, C., et al.
Publicado: (2022)

Clinicopathological characteristics and treatment outcome in obese patients with diffuse large B-cell lymphoma
por: Wu, Yu-Ying, et al.
Publicado: (2020)

Immunohistochemical and Molecular Characteristics with Prognostic Significance in Diffuse Large B-Cell Lymphoma
por: Bellas, Carmen, et al.
Publicado: (2014)

Characteristics of diffuse large B‐cell lymphoma in patients with primary Sjögren's syndrome
por: Gorodetskiy, Vadim Romanovich, et al.
Publicado: (2020)

Stem cell characteristics promote aggressiveness of diffuse large B-cell lymphoma
por: Chang, Kung-Chao, et al.
Publicado: (2020)

Single‐cell profiling‐guided combination therapy of c‐Fos and histone deacetylase inhibitors in diffuse large B‐cell lymphoma
por: Wang, Luqiao, et al.
Publicado: (2022)

Rituximab-Based Therapy in Newly Diagnosed Diffuse Large B-Cell Lymphoma Patients: Individualized Risk-Adapted Therapy Approach Using Molecular Subtypes
por: Fan, Lei, et al.
Publicado: (2017)

Central nervous system involvement of primary renal lymphoma with diffuse large B-cell type lymphoma
por: Hu, Rong, et al.
Publicado: (2013)

Transformation of a Cutaneous Follicle Center Lymphoma to a Diffuse Large B-Cell Lymphoma—An Unusual Presentation
por: Dias Coelho, J., et al.
Publicado: (2010)

Expression of P63 and its correlation with prognosis in diffuse large B-cell lymphoma: a single center experience
por: Hu, Wan-Ming, et al.
Publicado: (2019)

Characteristics of premanufacture CD8(+) T cells determine CAR-T efficacy in patients with diffuse large B-cell lymphoma
por: Wang, Yao, et al.
Publicado: (2023)

Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Subtype of the Thyroid
por: Waqar, Syed Hamza Bin, et al.
Publicado: (2021)

Primary Diffuse Large B Cell Lymphoma of Bone: A Single-Center Experience
por: Ayesh Haj Yousef, Mahmoud H, et al.
Publicado: (2022)

Impact of initial chemotherapy cycles and clinical characteristics on outcomes for HIV-associated diffuse large B cell lymphoma patients: The Central and Western China AIDS Lymphoma League 001 study (CALL-001 study)
por: Wang, Chaoyu, et al.
Publicado: (2023)

Targeting Bruton tyrosine kinase using non-covalent inhibitors in B cell malignancies
por: Gu, Danling, et al.
Publicado: (2021)

Characteristics of Extranodal NK/T-Cell Lymphoma, Nasal Type, Compared with Nasal Diffuse Large B-cell Lymphoma
por: Tanaka, Hirotaka, et al.
Publicado: (2023)

Characteristics and Management of TP53-Mutated Diffuse Large B-Cell Lymphoma Patients
por: Qin, Yan, et al.
Publicado: (2020)

The effectiveness of rituximab and HIV on the survival of Ontario patients with diffuse large B‐cell lymphoma
por: Habbous, Steven, et al.
Publicado: (2020)

Primary diffuse large B cell lymphoma of the prostate in a patient with HIV infection
por: Ujiie, Takashi, et al.
Publicado: (2022)

Germinal-center type B-cell classification and clinical characteristics of Chinese pediatric diffuse large B-cell lymphoma: a report of 76 cases
por: Chen, Yan, et al.
Publicado: (2013)

PB2373: A SINGLE-CELL ATLAS OF HIV-ASSOCIATED DIFFUSE LARGE B-CELL LYMPHOMA
por: Zhang, Xiaomei, et al.
Publicado: (2023)

Low Serum Cholesterol Level Is a Significant Prognostic Factor That Improves CLL-IPI in Chronic Lymphocytic Leukaemia
por: Gao, Rui, et al.
Publicado: (2023)

Gastric Diffuse Large B-Cell Lymphoma: A Single-Center 9-Year Experience
por: Couto, Maria Eduarda, et al.
Publicado: (2021)

The gut microbiota correlate with the disease characteristics and immune status of patients with untreated diffuse large B-cell lymphoma
por: Lin, Zhouning, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_n14ng8i3bvtt17nddqmh15ehpn